about
Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular SystemsComparison of carotid plaque tissue characteristics in patients with acute coronary syndrome or stable angina pectoris: assessment by iPlaque, transcutaneous carotid ultrasonography with integrated backscatter analysis.Ventricular tachycardia in cardiac sarcoidosis controlled by radiofrequency catheter ablation.Congenital long QT syndrome with compound mutations in the KCNH2 gene.Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension.Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery diseaseThe Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndromeLeft ventricular geometry and myocardial contractility in patients with essential hypertension evaluated by myocardial velocity profile.Gender disparities in the association between epicardial adipose tissue volume and coronary atherosclerosis: a 3-dimensional cardiac computed tomography imaging study in Japanese subjectsCross sectional echocardiographic demonstration of the mechanisms of abnormal interventricular septal motion in congenital total absence of the left pericardium.Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy.Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE studyImpact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study.Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).Diastology 2010: clinical approach to diastolic heart failure.Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.Prognostic Implications of Non-Invasive Vascular Function Tests in High-Risk Atherosclerosis Patients.Rest and exercise echocardiography for early detection of pulmonary hypertension.Prediction of Future Overt Pulmonary Hypertension by 6-Min Walk Stress Echocardiography in Patients With Connective Tissue Disease.Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography.Purulent Pericarditis Accompanying Pericardial Abscess Induced by Nocardia in an Immunocompromised Patient.Correlation Between Arteriosclerosis and Periodontal Condition Assessed by Lactoferrin and α1-Antitrypsin Levels in Gingival Crevicular Fluid.Impact of supervised cardiac rehabilitation on urinary albumin excretion in patients with cardiovascular disease.Echocardiographic screening for congenital heart disease in 8819 children: A report from local community events for children's healthcare.Subclinical Carotid Atherosclerosis Burden in the Japanese: Comparison between Okinawa and Nagano Residents.Plasma microRNA-100 is associated with coronary plaque vulnerability.The physiological uptake pattern of (18)F-FDG in the left ventricular myocardium of patients without heart disease.Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis.Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function.Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.Erratum to: 'Reduced ratio of eicosapentaenoic acid and docosahexaenoic acid to arachidonic acid is associated with early onset of acute coronary syndrome'.Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging.Pentraxin 3 is a local inflammatory marker in atrial fibrillation.Early systolic mitral annular motion velocities responses to dobutamine infusion predict myocardial viability in patients with previous myocardial infarction.
P50
Q27010641-61319F89-A1F5-401F-8FA4-84FDF4E03D0DQ30406330-E5F45C31-872C-48B8-ACB8-69988AAD40FFQ33160091-B02F2A1C-9732-49A8-B0BA-6DE5123DED6CQ33163304-C724C9D5-0CF9-4629-90C9-823F7A4E8050Q33660548-DB68B953-BEEE-4CE2-8C32-AE15C3D693D6Q34672517-3FA735FB-6CCC-4F86-9C27-7EB10BABCDADQ34977468-4B62C439-310B-4BA0-A7F3-E572567D5B82Q35341268-BCDBEE67-A550-4B76-A71D-ED6B595CAE12Q36063048-253B9374-FA9C-4F34-A58E-BB143D692559Q36232346-D9902AA3-F802-4760-9C3A-C405B4F0A695Q36308483-68293D21-5CD2-43B0-8554-0C82D22A71C9Q36373276-1C3DEF6B-8E6E-4E6F-ADF5-3D5EF0393FBDQ36841190-FE8713E7-19C5-4482-9C02-0732683A9EACQ36982543-ED752F32-41D3-4178-A1EF-924EABEFE482Q37018125-31E3E111-E265-479D-9B7E-AC84557F2BE7Q37251449-17D75898-120D-4500-896B-9770984C5E13Q37254915-E6AB358B-5287-49DA-97AB-24CC461286BFQ37390839-2123153D-5ACB-4819-B87A-B8E160E2AB28Q38680595-766105EB-861B-4CA4-B023-133296FDDD09Q38859585-CE8E7A9D-294F-4FB6-A892-32CFB2912386Q38894035-C0FC362A-8926-40A5-AA8C-61F8B6FD52D7Q38900830-90B6BF70-4144-4875-8B78-64B35847ADCEQ38937063-C353E52C-2102-4BEC-A1FC-70796E671134Q38981760-499EF3F2-1CC3-4AA0-8D4D-911C7608A60EQ39699395-803FEB9C-0FB8-4F8C-9B62-D8AC36D665B1Q40483627-BAB56655-2C75-4275-B1D9-D4F97A79686FQ41139592-EC7C8FC7-AEE2-408E-A150-26126678B7C4Q41288170-FD7A153A-8713-4BA3-B897-3D3E483374DFQ41604342-09C3A1D6-292E-437A-ADEB-E66228973B8AQ41622358-30848437-EA67-4B04-B42B-F79965077202Q41677324-4130ABF7-E78E-4149-9848-5A5C4DF147F9Q42456954-1F3D32AD-196E-4003-BEDF-01C7E2E4FA46Q42837427-69759C3D-EA25-4189-B8FC-C7DA6977B408Q42971652-EC20553B-655B-4F04-AD7C-7318E2170314Q43143752-0628C261-2306-41BB-8F78-4759F5B95774Q43147245-D637F465-5A5F-4671-A913-0766BCB8D72FQ43164610-E333D84F-A418-4235-B0C2-9E129A2AB29FQ43584391-D06A40CB-F54D-4E13-9E42-E5BD44455001Q43824291-433BF0EE-39F9-4392-89E2-28C7008416B5Q43898425-5312CED8-4CAD-4A01-B867-3419833D9FFA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hirotsugu Yamada
@ast
Hirotsugu Yamada
@en
Hirotsugu Yamada
@es
Hirotsugu Yamada
@sl
type
label
Hirotsugu Yamada
@ast
Hirotsugu Yamada
@en
Hirotsugu Yamada
@es
Hirotsugu Yamada
@sl
prefLabel
Hirotsugu Yamada
@ast
Hirotsugu Yamada
@en
Hirotsugu Yamada
@es
Hirotsugu Yamada
@sl
P106
P21
P31
P496
0000-0003-3741-5560
P569
2000-01-01T00:00:00Z